The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients—a retrospective study

BACKGROUND AND AIMS: The roles of sodium-glucose cotransporter 2 inhibitor (SGLT2i) in acute heart failure (AHF) risk after acute myocardial infarction (AMI) remain unclear. In this study, we explored the correlation between SGLT2i administration and short-term in-hospital AHF risk in AMI patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yi, Zhang, Jia-li, Jin, Hong, Ji, Yuan, Wang, Fang-fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228823/
https://www.ncbi.nlm.nih.gov/pubmed/37260943
http://dx.doi.org/10.3389/fcvm.2023.1158507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228823/
https://www.ncbi.nlm.nih.gov/pubmed/37260943
http://dx.doi.org/10.3389/fcvm.2023.1158507

Ejemplares similares